Indebted 发表于 2025-3-23 13:35:37

http://reply.papertrans.cn/43/4258/425798/425798_11.png

Ancillary 发表于 2025-3-23 16:11:06

Shanmugam Hemaiswarya,Pranav Kumar Prabhakar,Mukesh Doblerized primarily by a limitation in systolic pump performance, while the most obvious feature of HF with preserved ejection fraction (HFpEF) is diastolic dysfunction..The current therapeutic approach to HFrEF consists of staged neurohormonal modulation of the renin-angiotensin-aldosterone system (RAA

neoplasm 发表于 2025-3-23 21:28:24

http://reply.papertrans.cn/43/4258/425798/425798_13.png

调整 发表于 2025-3-23 23:53:31

http://reply.papertrans.cn/43/4258/425798/425798_14.png

Anguish 发表于 2025-3-24 05:37:36

Shanmugam Hemaiswarya,Pranav Kumar Prabhakar,Mukesh Dobleing the geriatric patient, the pediatric patient, and the pregnant patient.  Separate chapters discuss the unique challenges of positioning the patient, and of managing the patient taking anticoagulant and anti978-1-4939-4229-9978-1-4614-7363-3

Obvious 发表于 2025-3-24 08:09:49

Shanmugam Hemaiswarya,Pranav Kumar Prabhakar,Mukesh Dobleing the geriatric patient, the pediatric patient, and the pregnant patient.  Separate chapters discuss the unique challenges of positioning the patient, and of managing the patient taking anticoagulant and anti978-1-4939-4229-9978-1-4614-7363-3

MORT 发表于 2025-3-24 11:24:22

ndthose working in pharmaceutical and nutraceutical industries. This book could open up new strategies to focus on multiple targets to combat complex diseases unlike the single targeted drugs that are being cur978-981-19-5127-5978-981-19-5125-1

咒语 发表于 2025-3-24 16:34:07

Conclusion,re proceeding to clinical proofs. Many clinical and scientific data need to be generated for combination therapy which is currently very scanty. On the basis of scientific and clinically sound data, synergistic combinations and their benefits can be made available to the public.

巡回 发表于 2025-3-24 19:57:14

http://reply.papertrans.cn/43/4258/425798/425798_19.png

aggrieve 发表于 2025-3-25 00:23:50

Antagonistic Herb-Drug Interactions,ransport. Here we have summarized the antagonistic herb-drug interactions in various diseases along with the pharmacokinetic and pharmacodynamic characteristics. This chapter can help the physician and healthcare professionals as a reference and act accordingly to reduce the adverse effect due to these interactions.
页: 1 [2] 3 4 5 6 7
查看完整版本: Titlebook: Herb-Drug Combinations; A New Complementary Shanmugam Hemaiswarya,Pranav Kumar Prabhakar,Mukes Book 2022 The Editor(s) (if applicable) and